APUS

Apimeds Pharmaceuticals US, Inc.

NYSE MKT: APUS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.46

-9.93% today

Updated 2026-06-05

Market cap

$2.36M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.41

Dividend yield

—

52W range

$1 – $4

Volume

0.3M

Market cap

$2.36M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.41

Dividend yield

—

52W range

$1 – $4

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.06x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-1.75M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-1.03M	$-668666.00	$-777694.00	$-1.39M	$-1.78M
EPS	—	—	—	—	$-0.41
Free cash flow	$-823114.00	$-448167.00	$-627790.00	$-733526.00	$-1.75M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
APUS	$2.36M	22	4.3	3.0	5.0	7.3	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Apimeds Pharmaceuticals US, Inc. trades at $1.46. Our Smart Value Score of 22/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Apimeds Pharmaceuticals US, Inc.'s stock price?

Apimeds Pharmaceuticals US, Inc. (APUS) trades at $1.46.

Is Apimeds Pharmaceuticals US, Inc. overvalued?

Apimeds Pharmaceuticals US, Inc. carries a Smart Value Score of 22/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNYSE MKT

CurrencyUSD

www.mindwavedao.com

Quick metrics

P/S ratio—

ROE-63.20%

Beta—

50D MA$8.18

200D MA$16.57

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

APUS vs LLY →APUS vs JNJ →APUS vs ABBV →Stock screener →